Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Merger with CLS Labs (Details) - Business Acquisition, Pro Forma Information

v3.3.1.900
Note 3 - Merger with CLS Labs (Details) - Business Acquisition, Pro Forma Information - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2015
Feb. 28, 2015
Business Acquisition, Pro Forma Information [Abstract]    
Total revenue $ 0 $ 0
Net loss attributable to CLS Holdings USA, Inc. $ (338,919) $ (659,748)
Basic net income (loss) per common share $ (0.02) $ (0.04)
Diluted net income (loss) per common share $ (0.02) $ (0.04)
Weighted average shares - basic 15,000,000 15,000,000
Weighted average shares - diluted 15,000,000 15,000,000